Advisory Board Chair of Pharmaceutical Sciences
Shari O’Connor is a licensed pharmacist who has experience educating patients and care teams on what to expect from a prescribed regimen and how to properly store, handle, and administer specialty drugs throughout treatment. She has developed therapeutically focused clinical assessments as a central component of patient-centric model. She has helped developed individualized plans that allow the team to deliver targeted interventions focused on patient success.
She is actively participating in both State and Federal legislative areas for multiple state boards of pharmacy. She works with insurance companies, state health plans, and advocacy groups to develop standard and competency-based trainings to aid the management and coverage of many chronic diseases.
EDUCATION
Bachelor of Pharmaceutical Sciences PharmD, Minor in BusinessSaint John’s University, Jamaica, NY 1994; Clinical focus Infectious Disease/ HIV
Masters of BusinessTemple University, Philadelphia, PA 1998
LICENSES/CERTIFICATIONS
Currently Licensed for Pharmacy in New Jersey, Tennessee, Florida, Connecticut, North Carolina, South Carolina, Maryland, Massachusetts, New Hampshire, Illinois, and New York
CLINICAL INTERESTS
Immunology, Neurology, Infectious Disease, Tick Borne Illnesses, Autoimmune Encephalitis, Neuropathy, Fibromyalgia / CFS, Alzheimer’s, Neuropathy / CIDP, ADD / ADHD, Chronic Fatigue Syndrome, Multiple Sclerosis, Chronic Fatigue Syndrome, PANS/PANDA, ALS
Invisible International, Inc. is a MA nonprofit corporation operating through a fiscal sponsorship with Players Philanthropy Fund, a Maryland charitable trust recognized by IRS as a tax-exempt public charity under Section 501(c)(3) of the Internal Revenue Code (Federal Tax ID: 27-6601178). Contributions to Invisible International are tax-deductible to the fullest extent of the law.